Dr. Agarwala is a General Partner at Andreessen Horowitz (a16z), where she leads investments for the firm’s Bio + Health fund across biotech and digital health. She focuses on partnering with companies leveraging unique technologies and datasets to advance drug development, personalized medicine, and novel approaches to patient care delivery.
Her experience includes research at the prestigious Broad Institute in computational biology and human genetics. She completed her clinical residency at Stanford, and is board certified in internal medicine.
Dr. Agarwala holds M.D. and Ph.D. degrees from Harvard Medical School / MIT, and a B.S. degree in biophysics from Stanford University.